These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32927457)

  • 1. Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis.
    Mowla A; Shah H; Lail NS; Vaughn CB; Shirani P; Sawyer RN
    Cerebrovasc Dis; 2020; 49(5):503-508. PubMed ID: 32927457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
    Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
    Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
    Kamal H; Mehta BK; Ahmed MK; Kavak KS; Zha A; Lail NS; Shirani P; Al-Mufti F; Sawyer RN; Mowla A
    J Neurol Sci; 2021 Jan; 420():117265. PubMed ID: 33333324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
    Mowla A; Sharifian-Dorche M; Mehla S; Lail NS; Sharifian-Dorche A; Vaughn CB; Sawyer RN; Shirani P
    J Neurol Sci; 2021 Jun; 425():117451. PubMed ID: 33882341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IV thrombolysis and statins.
    Engelter ST; Soinne L; Ringleb P; Sarikaya H; Bordet R; Berrouschot J; Odier C; Arnold M; Ford GA; Pezzini A; Zini A; Rantanen K; Rocco A; Bonati LH; Kellert L; Strbian D; Stoll A; Meier N; Michel P; Baumgartner RW; Leys D; Tatlisumak T; Lyrer PA
    Neurology; 2011 Aug; 77(9):888-95. PubMed ID: 21849650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.
    Scheitz JF; Seiffge DJ; Tütüncü S; Gensicke H; Audebert HJ; Bonati LH; Fiebach JB; Tränka C; Lyrer PA; Endres M; Engelter ST; Nolte CH
    Stroke; 2014 Feb; 45(2):509-14. PubMed ID: 24368561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.
    Meier N; Nedeltchev K; Brekenfeld C; Galimanis A; Fischer U; Findling O; Remonda L; Schroth G; Mattle HP; Arnold M
    Stroke; 2009 May; 40(5):1729-37. PubMed ID: 19265056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
    Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of statin pre-treatment with baseline stroke severity and outcome in patients with acute ischemic stroke and received reperfusion treatment: An observational study.
    Escudero-Martínez I; Matusevicius M; Pavia-Nunes A; Sevcik P; Nevsimalova M; Rand VM; Kõrv J; Cappellari M; Mikulik R; Toni D; Ahmed N
    Int J Stroke; 2023 Feb; 18(2):201-207. PubMed ID: 35403505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Mowla A; Kamal H; Lail NS; Vaughn C; Shirani P; Mehla S; Rajabzadeh-Oghaz H; Deline C; Ching M; Crumlish A; Sawyer RN
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis?
    Zambrano Espinoza MD; Lail NS; Vaughn CB; Shirani P; Sawyer RN; Mowla A
    Cerebrovasc Dis; 2021; 50(2):141-146. PubMed ID: 33423033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY; Lin HJ; Sung SF; Yang YH; Lai EC; Hsieh HC; Chen CH
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.